March 30 (Reuters) - Revelation Biosciences Inc
REVB.O :
* REVELATION BIOSCIENCES INC. ANNOUNCES FINANCIAL RESULTS
FOR THE
THREE AND TWELVE MONTHS ENDED DECEMBER 31, 2022 AND RECENT
CORPORATE PROGRESS
* REVELATION BIOSCIENCES INC - BELIEVES THAT ITS CURRENT
CASH AND
CASH EQUIVALENTS ARE SUFFICIENT TO FUND OPERATIONS THROUGH JUNE
OF 2024
* REVELATION BIOSCIENCES INC- QTRLY LOSS PER SHARE $1.77
Source text for Eikon: ID:nBw1C5nxha
Further company coverage: REVB.O
((Reuters.Briefs@thomsonreuters.com;;))